Detalhe da pesquisa
1.
Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome.
Proc Natl Acad Sci U S A;
118(15)2021 04 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33833053
2.
Brief Report: Cell Cycle Dynamics of Human Pluripotent Stem Cells Primed for Differentiation.
Stem Cells;
37(9): 1151-1157, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31135093
3.
A transient DMSO treatment increases the differentiation potential of human pluripotent stem cells through the Rb family.
PLoS One;
13(12): e0208110, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30540809
4.
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.
Sci Transl Med;
9(381)2017 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28298418
5.
SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
Clin Cancer Res;
22(20): 5109-5119, 2016 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27126995
6.
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells.
MAbs;
7(5): 946-56, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26083076
7.
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential.
PLoS One;
10(9): e0137345, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26390038